Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Heregger, R; Huemer, F; Hutarew, G; Hecht, S; Cheveresan, L; Kotzot, D; Schamschula, E; Rinnerthaler, G; Melchardt, T; Weiss, L; Greil, R.
Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Group Medical Tumor Therapy next-generation sequencing registry and discussion of the literature.
ESMO Open. 2021; 6(4):100233 Doi: 10.1016/j.esmoop.2021.100233 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Co-authors Med Uni Graz
Rinnerthaler Gabriel
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Metastatic pheochromocytoma and paraganglioma (PPGL) are rare diseases with dismal prognosis and standard therapies are lacking. We herein report the first case of a germline anaplastic lymphoma kinase (ALK) mutation in a patient with chemorefractory metastatic pheochromocytoma in the absence of mutations of known PPGL-associated predisposing genes. Therapy with the ALK inhibitor (ALKi) brigatinib led to dramatic and durable disease remission, despite previous disease progression on the ALKi alectinib. This case underscores the potential clinical use of molecular profiling in rare diseases with limited treatment options and suggests that the ALK-R1192P point mutation might predict sensitivity to brigatinib.
Find related publications in this database (using NLM MeSH Indexing)
Adrenal Gland Neoplasms - drug therapy, genetics
Anaplastic Lymphoma Kinase - genetics
Austria - administration & dosage
High-Throughput Nucleotide Sequencing - administration & dosage
Humans - administration & dosage
Lung Neoplasms - administration & dosage
Mutation - administration & dosage
Organophosphorus Compounds - administration & dosage
Pheochromocytoma - diagnostic imaging, drug therapy, genetics
Pyrimidines - administration & dosage
Registries - administration & dosage

Find related publications in this database (Keywords)
pheochromocytoma
ALK
brigatinib
NGS
© Med Uni GrazImprint